EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Novel Prognostic Inflammation Index to Predict Poor Outcomes in Patients With Intracerebral Hemorrhage: A Longitudinal Study

Guangyong Chen iD, Feng Chen, Xin Lu, Zhangjing Zhu, Fangyan Chen, Qian Liu, Ziming Ren, Changhao Zhang, Yuxin Zhu, Yueping Chen, Suwen Huang, Dehao Yang und 1 weitere

CNS Neuroscience & Therapeutics · 2026-04 · 32 (4)

DOI: 10.1002/cns.70904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 27.04.2026. Verfasst von Guangyong Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Inflammation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Innovation and Entrepreneurship Training Program for College Students, Wenzhou Municipal Sci-Tech Bureau Program, Zhejiang Provincial Science and Technology Innovation Program (New Young Talent Program) for College Students.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spontaneous intracerebral hemorrhage (ICH) is an acute cerebrovascular disease associated with high mortality and severe disability. Inflammation plays a critical role in the onset and progression of ICH. However, existing inflammatory markers have limited predictive capacity for the prognosis of ICH patients. This study aims to develop a novel Prognostic inflammation index (PII) based on leukocyte subset counts and evaluate its effectiveness in assessing the prognosis of ICH patients.

Methods

A total of 1021 consecutive ICH patients hospitalized between January 2021 and June 2023 were included as the derivation cohort. In addition, an internal temporal validation cohort of 366 patients hospitalized between January 2024 and December 2024 was assembled using identical inclusion/exclusion criteria. Using reduced‐rank regression (RRR) based on leukocyte subsets (including neutrophils, monocytes, lymphocytes, eosinophils, and basophils), we constructed the PII. Multivariate logistic regression was employed to analyze the associations between PII, its dynamic trajectories, and patient outcomes, including poor prognosis, all‐cause mortality, and stroke‐associated infections. The predictive performance of PII was illustrated using a nomogram, and its efficacy was compared to conventional inflammatory markers through receiver operating characteristic (ROC) curve analysis.

Results

Patients with elevated PII were significantly associated with poor outcomes at 3, 6, and 12 months, stroke‐associated infections, and all‐cause mortality within 1 year (all p < 0.05). PII trajectory analysis revealed that patients with persistently high PII had a substantially increased risk of poor outcomes ( p < 0.05). Moreover, compared to common systemic inflammatory markers such as the systemic immune‐inflammation index (SII), systemic inflammation response index (SIRI), and aggregate inflammation systemic index (AISI), PII showed generally favorable discriminative performance across most endpoints; however, the pairwise AUC comparisons were exploratory and some comparisons yielded borderline p values that should be interpreted cautiously.

Conclusion

PII, a composite inflammation index based on leukocyte subset counts, is an effective predictor of poor outcomes in ICH patients and shows favorable prognostic performance compared with traditional inflammatory markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageInflammationHumansMaleFemalePrognosisLongitudinal StudiesMiddle AgedAgedBiomarkersPredictive Value of TestsLeukocyte Count

Stichwörter der Autor:innen

inflammationintracerebral hemorrhageleukocyte subsetsprognosisprognostic inflammation index

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • The Second School of Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • The First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou, China.
  • The School of Mental Health, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • The School of Rehabilitation, Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Guangyong Chen, Yiyun Weng

Förderung

  • National Innovation and Entrepreneurship Training Program for College Students
  • Wenzhou Municipal Sci-Tech Bureau Program
  • Zhejiang Provincial Science and Technology Innovation Program (New Young Talent Program) for College Students

Zitieren

APA

Chen, G., Chen, F., Lu, X., Zhu, Z., Chen, F., Liu, Q., Ren, Z., Zhang, C., Zhu, Y., Chen, Y., Huang, S., Yang, D., & Weng, Y. (2026). Development of a Novel Prognostic Inflammation Index to Predict Poor Outcomes in Patients With Intracerebral Hemorrhage: A Longitudinal Study. CNS Neuroscience & Therapeutics, 32(4). https://doi.org/10.1002/cns.70904

Vancouver

Chen G, Chen F, Lu X, Zhu Z, Chen F, Liu Q, et al. Development of a Novel Prognostic Inflammation Index to Predict Poor Outcomes in Patients With Intracerebral Hemorrhage: A Longitudinal Study. CNS Neuroscience & Therapeutics. 2026;32(4). doi:10.1002/cns.70904

BibTeX
@article{Chen2026,
  author = {Chen, Guangyong and Chen, Feng and Lu, Xin and Zhu, Zhangjing and Chen, Fangyan and Liu, Qian and Ren, Ziming and Zhang, Changhao and Zhu, Yuxin and Chen, Yueping and Huang, Suwen and Yang, Dehao and Weng, Yiyun},
  title = {Development of a Novel Prognostic Inflammation Index to Predict Poor Outcomes in Patients With Intracerebral Hemorrhage: A Longitudinal Study},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {4},
  doi = {10.1002/cns.70904}
}
Kostenlos starten →